Christopher Manley and Kristen Scully Manley join Fox Chase

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

CHRISTOPHER MANLEY and KRISTEN SCULLY MANLEY joined Fox Chase Cancer Center.

Christopher Manley will serve as the director of interventional pulmonology in the Department of Medicine, and Kristen Scully Manley will serve as a hospitalist in the department of medicine.

“Dr. Manley’s expertise in pulmonary medicine makes him the perfect candidate for our new director of interventional pulmonology,” said David Weinberg, chair of the department of medicine.

He will join Fox Chase after finishing his interventional pulmonology fellowship at Beth Israel Deaconess Medical Center and Massachusetts General Hospital this summer.

Scully Manley most recently served as a member of the hospitalist team in the division of general medicine and primary care at Beth Israel Deaconess, where she was honored as Clinician of the Year in 2015.

YOU MAY BE INTERESTED IN

In this week's episode of The Cancer Letter Podcast, editor and publisher Paul Goldberg, and associate editor Jacquelyn Cobb revisit two of last week’s most-read stories: the growing recognition that early-onset colorectal cancer requires a new diagnostic mindset, and the life and legacy of Maura Gillison, the scientist whose discovery that most head and neck cancers are driven by HPV transformed the field. 
For decades, we have faced a central challenge in colorectal cancer screening. One in three eligible Americans—over 50 million people—remain unscreened despite established methods like colonoscopy or stool-based tests existing for decades. This gap persists even though early detection saves lives, and even as colorectal cancer is now the number one cancer killer for Americans under 50.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login